Speaking Engagements (Staff, Collaborators, Strategic Partners)

Speaking Engagements (Staff, Collaborators, Strategic Partners)


May 9 - 9, 2019
Redwood City, CA

Biopharma Innovation Meets Value-Based Care:  Piloting a Path Forward

Please join the MIT Club of Northern California as we welcome, Gigi Hirsch, Executive Director of the MIT Center for Biomedical Innovation  (CBI) and its NEWDIGS Initiative, for a discussion on biopharmaceutical innovation at the intersection of medicine, game theory, digital health, and machine learning.

In addition to heading-up CBI, Gigi is leading a Massachusetts-wide initiative called LEAPS focused on designing a next generation disease ecosystem that... Learn more

May 7 - 8, 2019
Stanford, CA

Gigi Hirsch will lead a panel:

Transforming Patient Outcomes One Disease at a Time:
MIT LEAPS and Rheumatoid Arthritis

The successful transition to value-driven healthcare requires that we advance from “trial and error” to “precision” medicine, where patients are confident that they are receiving the right treatment at the right time.  Addressing the current massive, complex knowledge gaps will require a new scalable approach to evidence generation and use across R&D and healthcare delivery.

The goal of the MIT LEAPS Project is to design and pilot a next... Learn more

May 4 - 4, 2019
New Orleans, LA

Mark Trusheim for FoCUS

April 4 - 4, 2019
Montreal, Ontario, Canada

Casey Quinn will represent the FoCUS Project in a Panel titled: HTA Reimbursement and Payment of Gene Therapy for Hemophilia

March 25 - 28, 2019
San Diego, CA

Jane Barlow will represent the FoCUS Project


December 12 - 12, 2018
Cambridge, MA

Casey Quinn will present FoCUS learnings at the MIT Center for Biomedical Innovation's BioMANufacturing Program Summit

November 7 - 7, 2018
Boston, MA

Mark Trusheim, for NEWDIGS, facilitating working sessions for this Harvard-MIT Center for Regulatory Science and BIO joint workshop.

October 30 - 31, 2018
New York, NY

Kimberly Freeman, for FoCUS

October 29 - 29, 2018
Silver Spring, MD

Mark Trusheim, for NEWDIGS

The FDA Oncology Center of Excellence, in collaboration with theUCSF-Stanford Centers of Excellence in Regulatory Science and Innovation (CERSI) will hold a public workshop to explore clinical trial designs and innovations that will aid in ioptimizing outcomes in early breast cancer.

October 22 - 24, 2018
Washington, DC

Mark Trusheim, for NEWDIGS

More information here.

October 22 - 25, 2018
Orlando, FL

Jane Barlow for FoCUS
AMCP Nexus 2018

October 3 - 5, 2018
La Jolla, CA

Colin Young, FoCUS, presenting a poster on Pipeline Research

September 24 - 24, 2018
Washington, DC

Mark Trusheim
ASGCT Value Summit

September 11 - 11, 2018
Dallas, TX

R. John Glasspool for FoCUS
MCRA 2018 Conference

May 19 - 23, 2018
Baltimore, MD

Jane Barlow for FoCUS

May 10 - 10, 2018
New York, NY

Mark Trusheim

May 8 - 9, 2018
Stanford, CA

R. John Glasspool & Gigi Hirsch
Leaders in Global Healthcare & Technology

May 5 - 5, 2018
Chicago, IL

Mark Trusheim for FoCUS


May 2 - 2, 2018
Beverly Hills, CA

Mark Trusheim for FoCUS
"Paying for the High Cost of Cures"

March 26 - 26, 2018
Paris, France

R. John Glasspool & Casey Quinn for FoCUS

March 21 - 22, 2018
Budapest, Hungary

Ariel Stern and Mark Trusheim will facilitate a day of interactive discussions on MAPPS and the Adapt Smart consortium using NEWDIGS Scenario Design Lab methodology


November 14 - 14, 2017
Washington, DC

(R. John Glasspool) Duke-Margolis Center for Health Policy Workshop

October 24 - 25, 2017
Washington, DC

(Kay Larholt) Real World Evidence Discussions & Overview of Related Projects

July 12 - 12, 2017
Boston, MA
May 24 - 24, 2017
Boston, MA

(Mark Trusheim) Adaptive Pathways and Platform Trials Discussion

May 10 - 11, 2017
Palo Alto, CA

(Gigi Hirsch) Panel: Real World Evidence: Hype or Reality? (John Glasspool, Moderator)

April 27 - 27, 2017
Boston, MA

(Mark Trusheim) Panel: Gene Therapy: Commercialization Readiness & Market Access Challenges

January 23 - 23, 2017
Washington, DC

(Gigi Hirsch) Panel: Adaptive Biomedical Innovations: The Way Forward (Stella Blackburn, Moderator)


December 12 - 12, 2016
Washington, DC

hosted by the National Cancer Policy Forum. (G.K. Raju)

October 5 - 5, 2016
La Jolla, CA

“The Impact of a New Healthcare Model: What Do Payers Think of Gene Therapies?” (Mark Trusheim)

September 21 - 21, 2016
New York, NY

NBER Pre-Conference on Economic Dimensions of Personalized and Precision Medicine

June 29 - 29, 2016
Philadelphia, PA

“Europe and the US: Making Outcomes-Based Health Care Possible.” Details here. (Gigi Hirsch).

June 26 - 30, 2016
Philadelphia, PA

(Gigi Hirsch & Hans-Georg Eichler – Session Co-Chairs).

June 8 - 8, 2016
San Francisco, CA

“Curative Therapies: Aligning Policy with Science to Ensure Patient Access” (Mark Trusheim).

April 21 - 22, 2016
Duke University, Durham, NC

“Adaptive Pathways and Biomedical Innovation in the EU, US and Japan” (Ken Oye).

April 21 - 22, 2016
Washington, DC

“Adaptive Biomedical Innovation: Re-engineering How We Innovate” (Gigi Hirsch).

April 14 - 14, 2016
Basel, Switzerland
March 21 - 22, 2016
San Francisco, CA

co-sponsored by Silicon Valley Executive Network (SVEN), Decision Resources Group, and MIT Media Lab. “Adaptive Biomedical Innovation: Transforming Big Data Hype into Patient Value” (Tom Unger).

March 17 - 18, 2016

Belgian Healthcare Knowledge Center (HKC) & WHO jointly sponsored Drug Pricing Scenarios Project (Report to be presented to Dutch EU Presidency in June 2016) – Part 1 (Mark Trusheim).

January 27 - 29, 2016
Washington, DC

Panel Debate on “Earlier Access vs. Safety?” (Hans-Georg Eichler & Ken Oye).